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AbstrACt
Introduction In the past decade, evidence has emerged 
suggesting a potential link between contact sport 
participation and increased risk of late neurodegenerative 
disease, in particular chronic traumatic encephalopathy. 
While there remains a lack of clear evidence to test the 
hypothesis that contact sport participation is linked to an 
increased incidence of dementia, there is growing public 
concern regarding the risk. There is, therefore, a pressing 
need for research to gain greater understanding of the 
potential risks involved in contact sports participation, and 
to contextualise these within holistic health benefits of 
sport.
Methods and analysis Football’s InfluencE on Lifelong 
health and Dementia risk is designed as a retrospective 
cohort study, with the aim to analyse data from former 
professional footballers (FPF) in order to assess 
the incidence of neurodegenerative disease in this 
population. Comprehensive electronic medical and death 
records will be analysed and compared with those of a 
demographically matched population control cohort. As 
well as neurodegenerative disease incidence, all-cause, 
and disease-specific mortality, will be analysed in order to 
assess lifelong health. Cox proportional hazards models 
will be run to compare the data collected from FPFs to 
matched population controls.
Ethics and dissemination Approvals for study have 
been obtained from the University of Glasgow College of 
Medical, Veterinary and Life Sciences Research Ethics 
Committee (Project Number 200160147) and from 
National Health Service Scotland’s Public Benefits and 
Privacy Panel (Application 1718-0120).
IntroduCtIon 
Approximately 850 000 people in the UK are 
living with dementia, with an annual cost to 
society of £26 billion.1 Identifying possible 
risk factors for neurodegenerative disease 
and acting to reduce these is a priority. In 
the past decade, concerns around perceived 
increased dementia risk through participa-
tion in contact sports have led to numerous 
news headlines,2 a Hollywood movie3 and 
demands from media and governments for 
research into the issues raised. In part, this 
has been driven by growing recognition 
of a specific form of neurodegenerative 
pathology thought to be a consequence of 
exposure to traumatic brain injury (TBI), 
chronic traumatic encephalopathy (CTE),4 in 
autopsy studies of athletes from a wide range 
of contact sports, including American foot-
ball, association football (soccer; hereafter 
‘football’) and rugby.5–7 Nevertheless, despite 
this attention, there remain limited data to 
inform on the lifelong neurological conse-
quences of participation in contact sport, 
including dementia risk.
Regarding football, CTE pathology (then 
referred to as dementia pugilistica) was first 
reported in a former amateur footballer 
at the end of the last century.8 Since then, 
seven further published case descriptions of 
CTE neuropathology in former footballers 
have been reported.5 However, issues of case 
strengths and limitations of this study
 ► Utilising a comprehensive dataset of former pro-
fessional footballers  (FPF) and matched population 
controls (MPC) minimises risks of bias. 
 ► Accessing complete electronic health records, 
Football’s InfluencE on Lifelong health and Dementia 
risk has the opportunity to look at holistic lifelong 
health outcomes from professional football.
 ► Establishing a robust dataset on the primary aims 
will inform study design and target sample size for 
future research enquiries in this field.
 ► Errors in health records’ coding are widely rec-
ognised, but are assumed to be consistent between 
FPF and MPC.
 ► As a retrospective investigation of existing electronic 
health records data on specific risk factors for neu-
rodegeneration of interest, in particular exposure 
to traumatic brain injury, will be limited. These will 
require to be addressed in follow-on studies using 
different methodologies.
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selection bias and reporting limitations in these autopsy 
studies mean the few cases reported so far provide no 
insight into incidence of CTE in former footballers, nor 
do they inform on risk of neurodegenerative disease in 
this population.
Beyond CTE, data on the long-term neurological 
consequences of participation in sport are limited and 
conflicting. Thus, regarding American Football, while 
one study reported a threefold increase in neurodegen-
erative mortality in a cohort of former National Football 
League players,9 studies in former high school Amer-
ican footballers failed to identify any increased dementia 
risk.10 Regarding late neurocognitive impact of participa-
tion in contact sport, mild, subclinical deficits in limited 
neuropsychological assessments have been documented 
in former elite rugby union players when compared with 
matched controls;11 observations since replicated in other 
studies.12 In American football, a study of retired players 
concluded that those who had suffered multiple concus-
sions were more likely to be diagnosed with some degree 
of cognitive impairment.13
In association football, incidence of amyotrophic lateral 
sclerosis (ALS) has been documented as higher in former 
Italian professional footballers than expected from popu-
lation statistics.14 However, methodological limitations, 
including just five ALS cases in their study population 
of over 7000, and failure to use appropriately matched 
population data, mean these results must be interpreted 
with caution. Elsewhere, a separate study reported 11% 
of former footballers screening positive for cognitive 
impairment in a self-assessment survey, which is in line 
with population expectations.15 Again, however, inter-
pretation of this study is hampered by significant meth-
odological limitations, including modest recruitment 
numbers, selection bias in self-reporting of symptoms and 
failure to identify an appropriately matched community 
control population. Therefore, given the lack of robust, 
adequately powered studies with appropriate population 
controls no meaningful conclusion on late neurodegen-
erative disease risk in former athletes, including footbal-
lers can be drawn.
While the late neurocognitive consequences of partic-
ipation in sport remain uncertain, the health benefits of 
physical activity are long established. Specifically, regular 
physical activity is recognised as a benefit in both primary 
and secondary prevention of a range of chronic diseases,16 
including dementia,17 and in reducing risk of premature 
death;16 findings promoted by Public Health England18 
and the Center for Disease Control.19 Indeed, while 
studies in late neurocognitive outcomes in sport provide 
limited insight regarding their primary aims, by contrast 
they provide consistent support for lifelong health bene-
fits of sports participation. Thus, in reporting increased 
neurodegenerative mortality in former NFL footballers 
the authors also noted reduced all-cause mortality,9 while 
others report reduced cardiovascular disease in former 
rugby internationalists compared with their matched 
controls.11
Given growing public anxieties over perceived increased 
risk of dementia in former professional athletes, in 
particular former footballers, establishing robust data to 
inform on late neurodegenerative outcomes of participa-
tion in contact sports is a priority to inform public health 
policy and sports’ governing organisations. Importantly, 
however, insight into risk of neurodegenerative disease 
must be read in context of wider lifelong health outcomes 
to permit adequately informed discussions on the holistic 
public health implications of sport. Using established 
protocols that have proven highly successful in addressing 
similar research aims in other populations of interest.20–22 
Football’s InfluencE on Lifelong health and Dementia 
risk (FIELD) is designed as a retrospective cohort study 
looking at a wide range of physical and mental health 
outcomes, including neurodegenerative disease, in 
former professional footballers (FPF)compared with an 
age, sex and deprivation matched general population 
comparison group. The specific aims of the FIELD study 
are:
 ► To compare the incidence of neurodegenerative 
disease, including dementia, in FPF to a matched 
general population comparison group.
 ► To compare the incidence of chronic physical and 
mental health conditions in FPF to a matched general 
population comparison group.
 ► To compare all-cause and disease-specific mortality 
in FPF to a matched general population comparison 
group.
 ► To register former footballers for autopsy brain dona-
tion for diagnostic assessment at the time of death 
to inform on neurodegenerative pathologies in this 
population.
MEthods And AnAlysIs
Cohort identification
FPF will be identified from independent databases of all 
Scottish professional footballers held as the Record of 
Pre-war Scottish League Players (v2) and the Record of 
Post-war Scottish League Players (v6). These databases 
comprise comprehensive datasets of information on every 
player for all Scottish League clubs and have been compiled 
from the archives of the Scottish Football Museum and 
the individual league clubs. Included in these datasets are 
basic player demographics (full name and date of birth), 
together with extensive career information (including, 
where available, date of first signing and retirement, 
number of match appearances and player position). From 
these databases, duplicate entries (eg, player recorded 
by more than one club over career) will be merged to a 
single player record and a cohort of FPF will be identi-
fied as: full name and date of birth available; and age 40 
years or over at 31 December 2016. Exclusion criteria will 
be: incomplete demographic information and age under 
40 years at 31 December 2016. The selection of an age 
cut-off of 40 years reflects the suggestion that there might 
be an earlier age at onset for neurodegenerative disease in 
former athletes,4 while also acknowledging that prevalence 
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of such disease is extremely low below this age.23 Alongside 
basic demographic information, data to support potential 
secondary analyses will be extracted, including years of 
playing professional football and player position.
MPC will be selected matched to age, sex and depriva-
tion for the FPF cohort on a 3:1 basis (ie, for every FPF, 
three MPC will be identified). The Information Services 
Division of NHS Scotland supports the electronic Data 
Research and Innovation Service (eDRIS)24 This data-
base also records last known postcode of residence for all 
individuals in Scotland, which is used to provide infor-
mation on area socioeconomic deprivation based on the 
Scottish Index of Multiple Deprivation (SIMD).24 The 
SIMD is derived from information on income, employ-
ment, health, education (including skills and training), 
housing and crime for each geographic area (by post-
code), with the data commonly accessed in quintiles of 
socioeconomic status, ranging from 1 (most deprived) to 
5 (least deprived).
health records interrogation
In addition to information on socioeconomic deprivation 
as SIMD, eDRIS provides research support and access 
to comprehensive inpatient and outpatient electronic 
medical and death certification records prospectively 
from 1981 to present day for all Scottish residents. Using 
available demographic information (full name and date 
of birth) probability matching will be used to match each 
FPF to their unique Community Health Index number, 
which will then be used to provide individual level data for 
FPF and their MPC on: outpatient attendances (SMR00), 
admissions to general acute (SMR01) and psychiatric 
(SMR04) hospitals, cancer registrations (SMR06), and 
death certification. These records include diagnostic 
codes (International Classification of Diseases 9/10) 
identifying the condition resulting in hospitalisation or 
death. The FIELD study launches on 1 March 2018 and is 
scheduled to run for 36 months, to 31 January 2021.
Autopsy registration
Using existing, approved protocols FPF will be invited to 
register for research brain banking in the event of death 
via open calls for registration and participant informa-
tion disseminated in partnership with supporting sports 
associations and charities (eg, The Jeff Astle Foundation). 
In the event of death, specimens will be retrieved using 
existing national neuropathology networks and protocols 
and directed to the unique, internationally recognised 
Glasgow TBI Archive for diagnostic evaluation and to 
support wider research access under the NHS Greater 
Glasgow and Clyde Bio-repository governance framework.
statistical analysis
Separate Cox proportional hazards models will be run for 
each of the health outcomes comparing FPF and MPC. 
Analyses will run univariately, and will also be repeated 
after adjustment for potential confounders including 
player position and length of career. We will stratify by 
date of birth in order to look at birth cohort effects. We 
will also test for statistical interactions and undertake 
subgroup analyses where these are found. Predicting a 
population prevalence of neurodegenerative disease in 
the age range under study of 2.5 per 100 population1 23 
and an average disease duration of 15 years, then to detect 
a 50% increase in disease incidence will require a sample 
size of 5653 for 80% power (alpha=0.05), or 7613 for 90% 
power (Stata V.14, 2015; StataCorp).
Patient and public involvement
There was no direct patient or public involvement in the 
development of the FIELD study protocol.
limitations
The study has some limitations. First, we have limited 
access to information on confounders beyond age, 
sex and deprivation status. Confounders such as family 
history, and genetic predisposition to certain diseases 
cannot be taken into account. Second, diagnostic coding 
is a limitation. We are restricted by how much informa-
tion is supplied on death certificates and by medical 
records, the listed cause of death may not take into 
account contributing factors for death. Finally, the NHS 
was not founded until 1948, and we therefore may have 
less complete medical records or no medical records at 
all for some players born prior to this time period.
Ethics and dissemination
All health data returned to researchers will be anony-
mised with no return to original identifying information. 
As a secondary data analysis, individual consent from FPF 
and MPC is not required.
Based on previous, highly successful enquiries from our 
group using this same methodology,20–22 we anticipate this 
study will generate multiple informative manuscripts for 
publication in high-impact journals. As a priority, we intend 
outputs reporting: incidence of neurodegenerative disease 
in FPF in context of wider lifelong health outcomes; cause 
of death statistics in FPF and influence of player position 
and playing era on incidence of neurodegenerative disease 
in FPF. Further, we anticipate data will be discussed in 
preliminary formats at appropriate scientific conferences.
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